<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Oxidized regnerated cellulose: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Oxidized regnerated cellulose: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Oxidized regnerated cellulose: Drug information</div><div class="clear"></div><div id="topicText">For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F148525"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Interceed;</li>
<li>Surgicel;</li>
<li>Surgicel Fibrillar;</li>
<li>Surgicel Nu-Knit;</li>
<li>Surgicel SNoW 1"x2";</li>
<li>Surgicel SNoW 2"x4";</li>
<li>Surgicel SNoW 4"x4"</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F148535"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Hemostatic Agent</li></ul></div>
<div class="block doa drugH1Div" id="F148526"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e590f407-a981-4bcb-87e2-a1fa67c2e693">Hemostasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hemostasis: Topical:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Surgicel: Minimal amounts in appropriate size of cellulose are laid or applied to the bleeding site or held firmly against the tissues until hemostasis occurs; remove excess material.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="62618747-afd8-4361-a944-26e834289bcb">Pelvic adhesion reduction</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pelvic adhesion reduction: Topical:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Interceed: Following hemostasis, apply in single layer on and between raw (denuded) surfaces.</p></div>
</div>
</div>
<div class="block doe drugH1Div" id="F148527"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F148511"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Cardiovascular: Vascular insufficiency (stenosis when applied as a wrap)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Intestinal obstruction (after small bowel biopsy) (Bakhit 2019)</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Difficulty in micturition (after prostatectomy), ureteral obstruction (after kidney resection)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylaxis (Corti 2021), angioedema (Corti 2021)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application-site burning, application-site edema (encapsulation)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Foreign body reaction (Lin 2014), headache, neurotoxicity, paralysis, paraplegia (after thoracotomy) (Brodbelt 2002), stinging sensation</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Blindness (when placed in anterior cranial fossa), optic neuropathy (compressive: after orbital surgery) (Arat 2006)</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Sneezing (epistaxis and rhinological procedures)</p></div>
<div class="block coi drugH1Div" id="F148520"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Interceed: Infection.</p>
<p style="text-indent:-2em;margin-left:2em;">Surgicel: Implantation into bone defects (eg, fractures); hemorrhage from large arteries or veins; nonhemorrhagic oozing; use as an adhesion prevention product; intraluminal procedures or use in open blood vessels. <b>Note:</b> Multiple products are available and contraindications may vary by product; also refer to manufacturer's labeling.</p></div>
<div class="block war drugH1Div" id="F148508"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Foreign body reactions: Have occurred. Remove excess product before surgical closure to facilitate absorption and reduce risk.</p>
<p style="text-indent:-2em;margin-left:4em;">• Pain/numbness/nerve damage/paralysis: Pain, numbness, nerve damage, and paralysis have been reported if used near a bony or neural space and/or the optic nerve and chiasm; use minimum amount necessary to achieve hemostasis.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>
<i>
<b>Dosage forms specific issues</b></i>:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Powder: Unintentional placement may result in powder scattering and device migration that may increase the risk of adhesion formation. Do not use in conjunction with autologous blood salvage circuits (fragments may pass through the transfusion filters of blood-scavenging system).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use (Interceed): Not indicated as a hemostatic agent. Appropriate means of achieving hemostasis must be employed. Safety and effectiveness in laparoscopic surgery or any procedures other than open (laparotomy) gynecologic microsurgical procedures have not been established. Also refer to manufacturer's labeling for additional warnings/precautions.</p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use (Surgicel): The material should not be moistened before insertion since the hemostatic effect is greater when applied dry. The material should not be <b>impregnated</b> with anti-infective agents or with other materials such as buffering or hemostatic substances. Remove as much of agent as possible with sterile water or saline solution after hemostasis is achieved. Do not leave in a contaminated or infected space without drainage. Always remove completely following hemostasis if applied in proximity to foramina in bone, areas of bony confine, the spinal cord, and/or the optic nerve and chasm; product may swell and exert unwanted pressure. Although packing or wadding sometimes is medically necessary, cellulose should not be used in this manner, unless it is to be removed after hemostasis is achieved. In urological procedures, care must be exercised to prevent plugging of the urethra, ureter, or a catheter. In otorhinolaryngologic surgery, ensure that the material is not aspirated by the patient (eg, controlling hemorrhage after tonsillectomy and controlling epistaxis). In cauterized areas, absorption could be prevented in chemically cauterized areas; cellulose use should not be preceded by application of silver nitrate or any other escharotic chemicals. Also refer to manufacturer's labeling for additional warnings/precautions.</p></div>
<div class="block foc drugH1Div" id="F148516"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;">Pad, External:</p>
<p style="text-indent:-2em;margin-left:4em;">Interceed: (10 ea)</p>
<p style="text-indent:-2em;margin-left:4em;">Surgicel Fibrillar: (10s, 24s)</p>
<p style="text-indent:-2em;margin-left:4em;">Surgicel Nu-Knit: (10s, 24s)</p>
<p style="text-indent:-2em;margin-left:4em;">Surgicel SNoW 1"x2": (10 ea)</p>
<p style="text-indent:-2em;margin-left:4em;">Surgicel SNoW 2"x4": (10 ea)</p>
<p style="text-indent:-2em;margin-left:4em;">Surgicel SNoW 4"x4": (10 ea)</p>
<p style="text-indent:-6em;margin-left:6em;">Powder, Absorbable:</p>
<p style="text-indent:-2em;margin-left:4em;">Surgicel: 3 g (5 ea)</p></div>
<div class="block geq drugH1Div" id="F148504"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block adm drugH1Div" id="F51062789"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical: Note:</b> Also refer to manufacturer's labeling for detailed administration instructions.</p>
<p style="text-indent:-2em;margin-left:4em;">Adhesion barrier (Interceed): Place into surgical area as directed.</p>
<p style="text-indent:-2em;margin-left:4em;">Pad (Surgicel): May be sutured or cut without fraying.</p>
<p style="text-indent:-2em;margin-left:4em;">Powder (Surgicel): Powder is dry; precise delivery under certain circumstances may be difficult. Do not trim applicator tip (applicator tip not intended for laparoscopic or other endoscopic use).</p></div>
<div class="block use drugH1Div" id="F148517"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Hemostasis (Surgicel):</b> Adjunctive use in surgical procedures to control capillary, venous, or small arterial hemorrhage when ligation or other conventional methods of control are impractical or ineffective.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Pelvic adhesion reduction (Interceed): </b>Adjuvant in open (laparotomy) gynecologic pelvic surgery for reducing the incidence of postoperative pelvic adhesions after meticulous hemostasis is achieved consistent with microsurgical principles.</p></div>
<div class="block cyt drugH1Div" id="F13299001"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F148512"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Silver Nitrate: May diminish the therapeutic effect of Cellulose (Oxidized Regenerated).<i> Risk X: Avoid combination</i></p></div>
<div class="block rep_considerations drugH1Div" id="F55799071"><span class="drugH1">Reproductive Considerations</span>
<p style="text-indent:-2em;margin-left:2em;">Information related to the use of topical hemostatic agents in gynecologic surgery is limited and use should be restricted to situations where preferred interventions are not ideal or are unsafe (ACOG 2020).</p>
<p style="text-indent:-2em;margin-left:2em;">Interceed is approved for use as an adjuvant in open (laparotomy) gynecologic pelvic surgery to reduce the incidence of postoperative adhesions. Pelvic adhesions may be associated with pain and infertility; however, it is not clear if use of cellulose (oxidized regenerated) improves fertility or decreases pain (Ahmad 2020; ASRM/SRS 2019).</p>
<p style="text-indent:-2em;margin-left:2em;">Surgicel is approved to control hemostasis associated with surgery and may be useful in gynecologic surgeries such as conization of the cervix, hysterectomy, and oophorectomy.</p></div>
<div class="block pri drugH1Div" id="F14206269"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;display:inline">Information related to the use of topical hemostatic agents in gynecologic surgery is limited and use should be restricted to situations where preferred interventions are not ideal or are unsafe (ACOG 2020). Interceed has been evaluated for the prevention of intraperitoneal adhesions associated with cesarean delivery (Chapa 2011; Rottenstreich 2020). Use of Surgicel as adjunctive treatment of hemorrhage at the cesarean incision site has been described (Sharma 2006).</p></div>
<div class="block pha drugH1Div" id="F148507"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Cellulose, oxidized regenerated is saturated with blood at the bleeding site and swells into a brownish or black gelatinous mass which aids in the formation of a clot. When used in small amounts, it is absorbed from the sites of implantation with little or no tissue reaction. In addition to providing hemostasis, oxidized regenerated cellulose also has been shown <i>in vitro</i> to have bactericidal properties. Its hemostatic effect is not enhanced by the addition of thrombin.</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F58188211"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Medical absorbable hemostatic fibre</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Traumacel pulvis</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Surgicel Fibrillar</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Clotto</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Ahmad G, Kim K, Thompson M, et al. Barrier agents for adhesion prevention after gynaecological surgery. <i>Cochrane Database Syst Rev</i>. 2020;3(3):CD000475. doi:10.1002/14651858.CD000475.pub4<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/32199406/pubmed" id="32199406" target="_blank">32199406</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  American College of Obstetricians and Gynecologists (ACOG). Topical hemostatic agents at time of obstetric and gynecologic surgery: ACOG committee opinion, number 812. <i>Obstet Gynecol</i>. 2020;136(4):e81-e89. doi:10.1097/AOG.0000000000004104<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/32976379/pubmed" id="32976379" target="_blank">32976379</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16406540">
<a name="16406540"></a>Arat YO, Dorotheo EU, Tang RA, Boniuk M, Schiffman JS. Compressive optic neuropathy after use of oxidized regenerated cellulose in orbital surgery: review of complications, prophylaxis, and treatment. <i>Ophthalmology</i>. 2006;113(2):333-337. doi:10.1016/j.ophtha.2005.11.003<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/16406540/pubmed" id="16406540" target="_blank">16406540</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30740208">
<a name="30740208"></a>Bakhit J, Rafique M, Pham TD. Proceed or palliate: Surgicel® mimicking tumor recurrence and causing a small bowel obstruction. <i>J Surg Case Rep</i>. 2019;2019(1):rjz012. doi:10.1093/jscr/rjz012<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/30740208/pubmed" id="30740208" target="_blank">30740208</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11995773">
<a name="11995773"></a>Brodbelt AR, Miles JB, Foy PM, Broome JC. Intraspinal oxidised cellulose (Surgicel) causing delayed paraplegia after thoracotomy--a report of three cases. <i>Ann R Coll Surg Engl</i>. 2002;84(2):97-99.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/11995773/pubmed" id="11995773" target="_blank">11995773</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Chapa HO, Venegas G, Vanduyne CP, Antonetti AG, Sandate JP, Silver L. Peritoneal adhesion prevention at cesarean section: an analysis of the effectiveness of an absorbable adhesion barrier. <i>J Reprod Med</i>. 2011;56(3-4):103-109.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/21542525/pubmed" id="21542525" target="_blank">21542525</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34513507">
<a name="34513507"></a>Corti MC, Thomas AD, Sayegh MN, Vernon K, Sherman C, Trainor R. Surgicel-induced anaphylaxis post permacath placement. <i>Cureus</i>. 2021;13(8):e16938. doi:10.7759/cureus.16938<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/34513507/pubmed" id="34513507" target="_blank">34513507</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Interceed (oxidized regenerated cellulose) [prescribing information]. Somerville, NJ: Ethicon Inc; March 2017.</div>
</li>
<li>
<div class="reference">
                  Larsson B. Efficacy of Interceed in adhesion prevention in gynecologic surgery: a review of 13 clinical studies. <i>J Reprod Med</i>. 1996;41(1):27-34.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/8855073/pubmed" id="8855073" target="_blank">8855073</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24745805">
<a name="24745805"></a>Lin B, Yang H, Cui M, Li Y, Yu J. Surgicel application in intracranial hemorrhage surgery contributed to giant-cell granuloma in a patient with hypertension: case report and review of the literature. <i>World J Surg Oncol</i>. 2014;12:101. doi:10.1186/1477-7819-12-101<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/24745805/pubmed" id="24745805" target="_blank">24745805</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society of Reproductive Surgeons. Electronic address: <a class="__cf_email__" data-cfemail="315042435c715042435c1f5e4356" href="/cdn-cgi/l/email-protection">[email protected]</a>; Practice Committee of the American Society for Reproductive Medicine in collaboration with the Society of Reproductive Surgeons. Postoperative adhesions in gynecologic surgery: a committee opinion. <i>Fertil Steril</i>. 2019;112(3):458-463. doi:10.1016/j.fertnstert.2019.06.027<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/31446904/pubmed" id="31446904" target="_blank">31446904</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Rottenstreich M, Rotem R, Hirsch A, et al. The use of absorbable adhesion barriers to reduce the incidence of intraperitoneal adhesions at repeat cesarean delivery. <i>Arch Gynecol Obstet</i>. 2020;302(1):101-108. doi:10.1007/s00404-020-05591-6<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/32415470/pubmed" id="32415470" target="_blank">32415470</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16408181">
<a name="16408181"></a>Sharma JB and Malhotra M, "Successful Management of Uterine Incision Hemorrhage in Caesarean Section With Topical Oxidized Regenerated Cellulose (Surgicel Nu Knit): A Case Report," <i>Arch Gynecol Obstet</i>, 2006, 274(2):115-6.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/oxidized-regnerated-cellulose-drug-information/abstract-text/16408181/pubmed" id="16408181" target="_blank">16408181</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Surgicel Original, Nu-Knit, and Fibrillar (oxidized regenerated cellulose) [prescribing information]. Somerville, NJ: Ethicon US LLC; October 2018.</div>
</li>
<li>
<div class="reference">
                  Surgicel Powder (oxidized regenerated cellulose) [prescribing information]. Somerville, NJ: Ethicon Inc; March 2019.</div>
</li>
<li>
<div class="reference">
                  Surgicel SNoW (oxidized regenerated cellulose) [prescribing information]. Somerville, NJ: Ethicon Inc; November 2019.</div>
</li></ol></div><div id="topicVersionRevision">Topic 10083 Version 73.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
